Details of the Drug
General Information of Drug (ID: DMJI6AM)
| Drug Name |
4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE; 156336-70-8; 4-[5-(4-chlorophenyl)-1H-pyrazol-3-yl]piperidine; CHEMBL75691; 4-(5-(4-chlorophenyl)-1H-pyrazol-3-yl)piperidine; L02; 1way; AC1L9MRB; Bionet2_000947; Oprea1_423246; MLS000706783; SCHEMBL2598428; KS-00001ZEP; MolPort-001-684-207; GELALLNTKKLQLM-UHFFFAOYSA-N; HMS2660H19; HMS1366L01; ZINC5974200; BDBM50059237; AKOS015868501; AKOS023968186; DB08061; MCULE-8931017804; SMR000334280; FT-0741308; 7L-015; 3-(4-Piperidinyl)-5-(4-chlorophenyl)pyrazole
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 261.75 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 2.7 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||


